Novartis provides healthcare solutions that address the evolving needs of patients and societies worldwide. Through innovative science and technology, we address some of society’s most challenging healthcare issues. Every day we work to discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Our vision is to be the most valued and trusted medicines company in the world.
Our broad portfolio of medicines includes treatments in the areas of ophthalmology; neuroscience; immunology, hepatology and dermatology; cardiovascular, renal and metabolism; oncology, including targeted therapies, immuno-oncology, chimeric antigen receptor T cells (CAR-T) and radioligand therapy; and gene therapies. We are also a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide.
Novartis actively engages with policy makers, elected officials, patients, payers, and other stakeholders to advocate for a US healthcare system that supports sustainable innovation, ensures patient access to the latest therapies, and values the impact medicines bring to patients, their families and society at large.